Chong Kun Dang and Humasis Jointly Sell COVID-19 Antigen Diagnostic Kits for Professionals

Humasis COVID-19 Antigen Diagnostic Kit.

[Asia Economy Reporter Lee Gwan-joo] Chong Kun Dang announced on the 15th that it has signed a joint sales agreement for a professional-use COVID-19 antigen test kit with Humasis, a company specializing in in vitro diagnostics.

Chong Kun Dang and Humasis will jointly sell the "Humasis COVID-19 Ag Test" to domestic hospitals and clinics conducting rapid COVID-19 antigen testing.

The Humasis COVID-19 antigen test kit is designed for professional use, featuring a longer and more flexible swab for specimen collection, which reduces discomfort for the tested individual. In collaboration with a national university in South Africa, an evaluation was conducted on 30 clinical specimens infected with the Omicron variant, confirming a sensitivity of 93.3% in detecting positive specimens. The kit has received approval from the Korean Ministry of Food and Drug Safety, the U.S. FDA, and the European CE, and is currently supplied to the U.S. Department of Defense, the Public Procurement Service, and Amazon.com, the world's largest shopping mall.

Following the Central Disaster and Safety Countermeasure Headquarters' decision from the 14th to recognize positive results from professional rapid antigen tests conducted at hospitals and clinics as confirmed cases for one month, Chong Kun Dang and Humasis plan to supply the test kits to approximately 7,700 respiratory-specialized clinics and designated respiratory treatment medical institutions nationwide.

Kim Young-joo, CEO of Chong Kun Dang, stated, "We expect Humasis' professional-use test kits, recognized domestically, in the U.S., and Europe, to enable accurate diagnosis and treatment of the COVID-19 virus," adding, "Based on our expertise in the respiratory field built through influenza treatments such as Tamiflu and Xofluza, we will promptly supply the test kits."

Cha Jung-hak, CEO of Humasis, said, "We are pleased to collaborate with Chong Kun Dang, which has excellent sales capabilities in the respiratory disease field," and added, "Through this joint sales agreement, we hope to contribute to ending COVID-19 by supplying our superior products more stably."

This content was produced with the assistance of AI translation services.